ID
40243
Description
Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid
Keywords
Versions (1)
- 3/24/20 3/24/20 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 24, 2020
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455
End of Double Blind - Administrative; Subject Continuation; Phase Conclusion
Description
Subject Continuation
Alias
- UMLS CUI-1
- C0805733 (Continuation status)
- LOINC
- MTHU008303
Description
If the subject is an early withdrawal, tick No for subject continuation If yes, complete the Phase conclusion section and proceed with the Open-label Period If No, complete the Phase conclusion section and proceed with the Follow-up Period
Data type
boolean
Alias
- UMLS CUI [1]
- C0805733 (Continuation status)
- LOINC
- MTHU008303
Description
Phase Conclusion
Alias
- UMLS CUI-1
- C1707478 (Conclusion)
- UMLS CUI-2
- C0205390 (Phase)
- SNOMED
- 21191007
Description
If yes, complete date and primary reason for withdrawal
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0805732 (Completion Status)
- UMLS CUI [1,2]
- C0231175 (Failed)
- UMLS CUI [2,1]
- C0205390 (Phase)
- SNOMED
- 21191007
- UMLS CUI [2,2]
- C2603343 (Study)
Description
Date subject failed to complete
Data type
date
Alias
- UMLS CUI [1,1]
- C0805732 (Completion Status)
- UMLS CUI [1,2]
- C0231175 (Failed)
- UMLS CUI [2,1]
- C0205390 (Phase)
- SNOMED
- 21191007
- UMLS CUI [2,2]
- C2603343 (Study)
- UMLS CUI [3]
- C0011008 (Date in time)
- SNOMED
- 410671006
Description
Primary reason for withdrawal
Data type
integer
Alias
- UMLS CUI [1,1]
- C0422727 (Patient withdrawn from trial)
- SNOMED
- 185924006
- UMLS CUI [1,2]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
Description
Specify Investigator discretion
Data type
text
Alias
- UMLS CUI [1,1]
- C2348235 (Specification)
- UMLS CUI [1,2]
- C0008961 (Clinical Investigators)
- UMLS CUI [1,3]
- C0022423 (Judgment)
- SNOMED
- 61254005
Description
Specify withdrew consent
Data type
text
Alias
- UMLS CUI [1,1]
- C1707492 (Consent Withdrawn)
- UMLS CUI [1,2]
- C2348235 (Specification)
Similar models
End of Double Blind - Administrative; Subject Continuation; Phase Conclusion
C2985720 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3])
C0392360 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
No comments